

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * regulation of skeletal muscle contraction (GO:0014819) | 9.23108217 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.84291395 |
| 3 | actin filament-based movement (GO:0030048) | 8.31688022 |
| 4 | myotube cell development (GO:0014904) | 7.52528234 |
| 5 | plasma membrane repair (GO:0001778) | 7.44945451 |
| 6 | glycogen catabolic process (GO:0005980) | 6.89806897 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.83428075 |
| 8 | striated muscle contraction (GO:0006941) | 6.78899508 |
| 9 | skeletal muscle tissue regeneration (GO:0043403) | 6.74152716 |
| 10 | creatine metabolic process (GO:0006600) | 6.70251164 |
| 11 | sarcomere organization (GO:0045214) | 6.48191954 |
| 12 | glucan catabolic process (GO:0009251) | 6.46154456 |
| 13 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.31825803 |
| 14 | cellular polysaccharide catabolic process (GO:0044247) | 6.01398416 |
| 15 | striated muscle atrophy (GO:0014891) | 5.99630581 |
| 16 | purine nucleotide salvage (GO:0032261) | 5.93217379 |
| 17 | response to muscle activity (GO:0014850) | 5.90992996 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.89679075 |
| 19 | polysaccharide catabolic process (GO:0000272) | 5.81978544 |
| 20 | carnitine shuttle (GO:0006853) | 5.76173687 |
| 21 | myofibril assembly (GO:0030239) | 5.75696001 |
| 22 | cytidine metabolic process (GO:0046087) | 5.74595219 |
| 23 | cytidine catabolic process (GO:0006216) | 5.74595219 |
| 24 | cytidine deamination (GO:0009972) | 5.74595219 |
| 25 | muscle contraction (GO:0006936) | 5.72197013 |
| 26 | response to inactivity (GO:0014854) | 5.62848420 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.58911795 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 5.50278833 |
| 29 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.47293166 |
| 30 | striated muscle adaptation (GO:0014888) | 5.27885309 |
| 31 | glucan biosynthetic process (GO:0009250) | 5.20355973 |
| 32 | glycogen biosynthetic process (GO:0005978) | 5.20355973 |
| 33 | muscle atrophy (GO:0014889) | 5.18850685 |
| 34 | muscle fiber development (GO:0048747) | 5.15240415 |
| 35 | IMP metabolic process (GO:0046040) | 5.07722176 |
| 36 | * muscle system process (GO:0003012) | 4.94877253 |
| 37 | NADH metabolic process (GO:0006734) | 4.91388657 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 4.86651285 |
| 39 | actomyosin structure organization (GO:0031032) | 4.60381069 |
| 40 | glycogen metabolic process (GO:0005977) | 4.57097826 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 4.55655783 |
| 42 | negative regulation of muscle hypertrophy (GO:0014741) | 4.49575209 |
| 43 | glucan metabolic process (GO:0044042) | 4.48001711 |
| 44 | cellular glucan metabolic process (GO:0006073) | 4.48001711 |
| 45 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.46975222 |
| 46 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.44121986 |
| 47 | fructose metabolic process (GO:0006000) | 4.43400834 |
| 48 | striated muscle hypertrophy (GO:0014897) | 4.34729180 |
| 49 | muscle cell fate commitment (GO:0042693) | 4.31482649 |
| 50 | carnitine transmembrane transport (GO:1902603) | 4.27291608 |
| 51 | muscle adaptation (GO:0043500) | 4.26826959 |
| 52 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.24699741 |
| 53 | muscle organ morphogenesis (GO:0048644) | 4.12242060 |
| 54 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.10546342 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 4.09205657 |
| 56 | response to activity (GO:0014823) | 4.07832161 |
| 57 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.06672373 |
| 58 | neuronal action potential propagation (GO:0019227) | 4.04536439 |
| 59 | gluconeogenesis (GO:0006094) | 4.03536908 |
| 60 | muscle organ development (GO:0007517) | 3.94081580 |
| 61 | muscle cell cellular homeostasis (GO:0046716) | 3.92001816 |
| 62 | muscle hypertrophy (GO:0014896) | 3.90613877 |
| 63 | amino-acid betaine transport (GO:0015838) | 3.89916387 |
| 64 | carnitine transport (GO:0015879) | 3.89916387 |
| 65 | muscle structure development (GO:0061061) | 3.88487836 |
| 66 | IMP biosynthetic process (GO:0006188) | 3.85411031 |
| 67 | cardiac muscle contraction (GO:0060048) | 3.83836926 |
| 68 | cellular carbohydrate catabolic process (GO:0044275) | 3.82130211 |
| 69 | muscle tissue morphogenesis (GO:0060415) | 3.81731798 |
| 70 | neuromuscular synaptic transmission (GO:0007274) | 3.80578696 |
| 71 | striated muscle cell development (GO:0055002) | 3.78549108 |
| 72 | myotube differentiation (GO:0014902) | 3.75499946 |
| 73 | skeletal muscle tissue development (GO:0007519) | 3.72272602 |
| 74 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.69383895 |
| 75 | regulation of coenzyme metabolic process (GO:0051196) | 3.67018248 |
| 76 | regulation of cofactor metabolic process (GO:0051193) | 3.67018248 |
| 77 | adult heart development (GO:0007512) | 3.66199651 |
| 78 | myoblast fusion (GO:0007520) | 3.65510443 |
| 79 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.64215019 |
| 80 | regulation of relaxation of muscle (GO:1901077) | 3.61917763 |
| 81 | hexose biosynthetic process (GO:0019319) | 3.61916466 |
| 82 | cellular response to dexamethasone stimulus (GO:0071549) | 3.58927396 |
| 83 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.55054043 |
| 84 | positive regulation of myotube differentiation (GO:0010831) | 3.54398397 |
| 85 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.53497985 |
| 86 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.53497985 |
| 87 | cardiac muscle cell development (GO:0055013) | 3.42253054 |
| 88 | striated muscle tissue development (GO:0014706) | 3.41497868 |
| 89 | * regulation of striated muscle contraction (GO:0006942) | 3.37658140 |
| 90 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.37565095 |
| 91 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.37565095 |
| 92 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.35815538 |
| 93 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.35193736 |
| 94 | muscle hypertrophy in response to stress (GO:0003299) | 3.35193736 |
| 95 | cardiac muscle adaptation (GO:0014887) | 3.35193736 |
| 96 | response to dexamethasone (GO:0071548) | 3.34595199 |
| 97 | tricarboxylic acid cycle (GO:0006099) | 3.33758976 |
| 98 | syncytium formation (GO:0006949) | 3.32680948 |
| 99 | ubiquinone biosynthetic process (GO:0006744) | 3.27218333 |
| 100 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.27128952 |
| 101 | neuromuscular junction development (GO:0007528) | 3.24458046 |
| 102 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.24221274 |
| 103 | muscle cell development (GO:0055001) | 3.23234975 |
| 104 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.22604423 |
| 105 | cellular polysaccharide metabolic process (GO:0044264) | 3.22409559 |
| 106 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.20978162 |
| 107 | AMP metabolic process (GO:0046033) | 3.18760827 |
| 108 | positive regulation of cation channel activity (GO:2001259) | 3.18693854 |
| 109 | cardiac cell development (GO:0055006) | 3.16845913 |
| 110 | positive regulation of myoblast differentiation (GO:0045663) | 3.14986404 |
| 111 | regulation of myotube differentiation (GO:0010830) | 3.12436316 |
| 112 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.11940417 |
| 113 | regulation of sequestering of triglyceride (GO:0010889) | 3.09366043 |
| 114 | polysaccharide biosynthetic process (GO:0000271) | 3.07545269 |
| 115 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.05675226 |
| 116 | regulation of actin filament-based movement (GO:1903115) | 3.05446783 |
| 117 | endoplasmic reticulum organization (GO:0007029) | 3.04071382 |
| 118 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.00824285 |
| 119 | regulation of sulfur metabolic process (GO:0042762) | 2.99818458 |
| 120 | regulation of myoblast differentiation (GO:0045661) | 2.98882069 |
| 121 | polysaccharide metabolic process (GO:0005976) | 2.98760310 |
| 122 | cellular carbohydrate biosynthetic process (GO:0034637) | 2.96621837 |
| 123 | cardiac myofibril assembly (GO:0055003) | 2.91776203 |
| 124 | actin-myosin filament sliding (GO:0033275) | 13.5508715 |
| 125 | muscle filament sliding (GO:0030049) | 13.5508715 |
| 126 | skeletal muscle contraction (GO:0003009) | 11.6083904 |
| 127 | actin-mediated cell contraction (GO:0070252) | 11.0967752 |
| 128 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.5426893 |
| 129 | skeletal muscle adaptation (GO:0043501) | 10.1812897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.40055952 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.50184619 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.44083656 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.26975137 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.10597175 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.04114284 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.76254315 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53605898 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.41876443 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36894497 |
| 11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.28836958 |
| 12 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.28836958 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.26922777 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.26306116 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.05885276 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96142167 |
| 17 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.95517105 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94302840 |
| 19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.84051694 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.81020608 |
| 21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.79955986 |
| 22 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.77727430 |
| 23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.75642412 |
| 24 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.75581194 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72556641 |
| 26 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.67887286 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66291393 |
| 28 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.63892200 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61506954 |
| 30 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.58751867 |
| 31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.56299985 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53153072 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49643169 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44551490 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41784560 |
| 36 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.38377888 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35663744 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35449243 |
| 39 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.34214159 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30867652 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27275090 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27216557 |
| 43 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.26740711 |
| 44 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.26706589 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25250726 |
| 46 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.23516499 |
| 47 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.22637315 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.21837624 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21154261 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21045154 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20200153 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19762222 |
| 53 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.18070306 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18059400 |
| 55 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.17779634 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.16803712 |
| 57 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.15446654 |
| 58 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13949667 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13401756 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12690953 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11140935 |
| 62 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09842284 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07765265 |
| 64 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07649455 |
| 65 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06676970 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06445975 |
| 67 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06206490 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04842550 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02994736 |
| 70 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02479386 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02245937 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01481732 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00636748 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00359124 |
| 75 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99878648 |
| 76 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99784855 |
| 77 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99586301 |
| 78 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99555985 |
| 79 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99117251 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98934703 |
| 81 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.97841760 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97034458 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96912038 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96671675 |
| 85 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96486666 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96486666 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95059195 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94614666 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94399021 |
| 90 | * P68_20966046_ChIP-Seq_HELA_Human | 0.94215089 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92700081 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92523549 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92443352 |
| 94 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90340740 |
| 95 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90029109 |
| 96 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89772259 |
| 97 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.89757431 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88930501 |
| 99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88452082 |
| 100 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.88368602 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87825049 |
| 102 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.87650269 |
| 103 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.87428937 |
| 104 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.87388224 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87119415 |
| 106 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.86971174 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86513869 |
| 108 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86450351 |
| 109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.86159149 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86009360 |
| 111 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.85952515 |
| 112 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85533069 |
| 113 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85182184 |
| 114 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85154357 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84822455 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84267461 |
| 117 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.84049263 |
| 118 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83754576 |
| 119 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83685349 |
| 120 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83591414 |
| 121 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.83180850 |
| 122 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.82830250 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82411608 |
| 124 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81951637 |
| 125 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81829727 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81276883 |
| 127 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.78723028 |
| 128 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78702068 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76024206 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75229971 |
| 131 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73997474 |
| 132 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.73747319 |
| 133 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72828870 |
| 134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71308441 |
| 135 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.70656308 |
| 136 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.70622578 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.70595901 |
| 138 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.69802421 |
| 139 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69143177 |
| 140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69143177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.94963841 |
| 2 | MP0000749_muscle_degeneration | 6.52901741 |
| 3 | MP0003646_muscle_fatigue | 6.25797721 |
| 4 | MP0000751_myopathy | 5.77547097 |
| 5 | MP0000747_muscle_weakness | 4.73045644 |
| 6 | * MP0002106_abnormal_muscle_physiology | 4.12088137 |
| 7 | * MP0000759_abnormal_skeletal_muscle | 3.79095556 |
| 8 | MP0002269_muscular_atrophy | 3.55015220 |
| 9 | * MP0005369_muscle_phenotype | 3.46980249 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.44541103 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.40882381 |
| 12 | MP0004130_abnormal_muscle_cell | 3.29223714 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.28386992 |
| 14 | * MP0004036_abnormal_muscle_relaxation | 3.19658008 |
| 15 | * MP0005620_abnormal_muscle_contractility | 2.98640746 |
| 16 | MP0004233_abnormal_muscle_weight | 2.51986749 |
| 17 | MP0000733_abnormal_muscle_development | 2.50826573 |
| 18 | MP0002108_abnormal_muscle_morphology | 2.23080382 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.18719922 |
| 20 | MP0005275_abnormal_skin_tensile | 1.97311283 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.81465205 |
| 22 | MP0005330_cardiomyopathy | 1.77460589 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.76661717 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.51089388 |
| 25 | MP0004270_analgesia | 1.50667129 |
| 26 | MP0002971_abnormal_brown_adipose | 1.47429511 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.38819767 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.37763277 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.19841635 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.13681896 |
| 31 | MP0004484_altered_response_of | 1.12666589 |
| 32 | MP0010630_abnormal_cardiac_muscle | 1.12577474 |
| 33 | MP0001661_extended_life_span | 1.10103010 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.09114544 |
| 35 | MP0002796_impaired_skin_barrier | 1.06505813 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.06050723 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.05994805 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03346746 |
| 39 | MP0004134_abnormal_chest_morphology | 0.98966756 |
| 40 | MP0005266_abnormal_metabolism | 0.98840371 |
| 41 | MP0002822_catalepsy | 0.97337140 |
| 42 | MP0003950_abnormal_plasma_membrane | 0.91634628 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 0.88208201 |
| 44 | MP0002234_abnormal_pharynx_morphology | 0.85579846 |
| 45 | MP0005503_abnormal_tendon_morphology | 0.83869133 |
| 46 | MP0000762_abnormal_tongue_morphology | 0.82454752 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 0.81255639 |
| 48 | MP0005385_cardiovascular_system_phenoty | 0.78119340 |
| 49 | MP0001544_abnormal_cardiovascular_syste | 0.78119340 |
| 50 | MP0009250_abnormal_appendicular_skeleto | 0.76886672 |
| 51 | MP0000372_irregular_coat_pigmentation | 0.75736397 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 0.75593530 |
| 53 | MP0001299_abnormal_eye_distance/ | 0.72271760 |
| 54 | MP0000579_abnormal_nail_morphology | 0.71869385 |
| 55 | MP0008961_abnormal_basal_metabolism | 0.64436076 |
| 56 | MP0003828_pulmonary_edema | 0.61732569 |
| 57 | MP0004085_abnormal_heartbeat | 0.61726895 |
| 58 | MP0003879_abnormal_hair_cell | 0.60432512 |
| 59 | MP0000003_abnormal_adipose_tissue | 0.59837618 |
| 60 | MP0004147_increased_porphyrin_level | 0.59555297 |
| 61 | MP0005334_abnormal_fat_pad | 0.59444360 |
| 62 | MP0003137_abnormal_impulse_conducting | 0.57988205 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.57497331 |
| 64 | MP0001243_abnormal_dermal_layer | 0.55174712 |
| 65 | MP0004043_abnormal_pH_regulation | 0.55147320 |
| 66 | MP0005501_abnormal_skin_physiology | 0.53249190 |
| 67 | MP0010030_abnormal_orbit_morphology | 0.53144324 |
| 68 | MP0005670_abnormal_white_adipose | 0.52507073 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 0.51084843 |
| 70 | MP0002896_abnormal_bone_mineralization | 0.50598956 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 0.50199452 |
| 72 | MP0000383_abnormal_hair_follicle | 0.49863232 |
| 73 | MP0000343_altered_response_to | 0.49493101 |
| 74 | MP0009672_abnormal_birth_weight | 0.48559010 |
| 75 | MP0000266_abnormal_heart_morphology | 0.47928566 |
| 76 | MP0005452_abnormal_adipose_tissue | 0.47647314 |
| 77 | MP0008569_lethality_at_weaning | 0.47087716 |
| 78 | MP0001346_abnormal_lacrimal_gland | 0.46118924 |
| 79 | MP0003959_abnormal_lean_body | 0.44640639 |
| 80 | MP0003045_fibrosis | 0.43415301 |
| 81 | MP0002638_abnormal_pupillary_reflex | 0.42738181 |
| 82 | MP0002060_abnormal_skin_morphology | 0.42458388 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42365892 |
| 84 | MP0008775_abnormal_heart_ventricle | 0.41700003 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.40915904 |
| 86 | MP0005083_abnormal_biliary_tract | 0.40399071 |
| 87 | MP0002127_abnormal_cardiovascular_syste | 0.39529885 |
| 88 | MP0001849_ear_inflammation | 0.39476430 |
| 89 | MP0000427_abnormal_hair_cycle | 0.38442736 |
| 90 | MP0002114_abnormal_axial_skeleton | 0.37334868 |
| 91 | MP0002128_abnormal_blood_circulation | 0.36266241 |
| 92 | MP0002734_abnormal_mechanical_nocicepti | 0.31586209 |
| 93 | MP0006138_congestive_heart_failure | 0.31501047 |
| 94 | MP0000377_abnormal_hair_follicle | 0.31135117 |
| 95 | MP0009115_abnormal_fat_cell | 0.31108935 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.30964229 |
| 97 | MP0005423_abnormal_somatic_nervous | 0.30159951 |
| 98 | MP0004142_abnormal_muscle_tone | 0.30111997 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.29457100 |
| 100 | MP0009931_abnormal_skin_appearance | 0.26893620 |
| 101 | MP0005451_abnormal_body_composition | 0.26118075 |
| 102 | MP0005332_abnormal_amino_acid | 0.25144114 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.23464202 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.22772887 |
| 105 | MP0010771_integument_phenotype | 0.22654489 |
| 106 | MP0000647_abnormal_sebaceous_gland | 0.22554607 |
| 107 | MP0002932_abnormal_joint_morphology | 0.22512546 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.21749662 |
| 109 | MP0004510_myositis | 0.21447596 |
| 110 | MP0008770_decreased_survivor_rate | 0.21183137 |
| 111 | MP0003385_abnormal_body_wall | 0.21082671 |
| 112 | MP0002066_abnormal_motor_capabilities/c | 0.21056597 |
| 113 | MP0005535_abnormal_body_temperature | 0.20919415 |
| 114 | MP0003755_abnormal_palate_morphology | 0.20762024 |
| 115 | * MP0003948_abnormal_gas_homeostasis | 0.20527861 |
| 116 | MP0005166_decreased_susceptibility_to | 0.19715246 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.19530125 |
| 118 | MP0005187_abnormal_penis_morphology | 0.19337925 |
| 119 | MP0005165_increased_susceptibility_to | 0.19216394 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.18369820 |
| 121 | MP0004858_abnormal_nervous_system | 0.18260720 |
| 122 | * MP0001943_abnormal_respiration | 0.18164882 |
| 123 | MP0004197_abnormal_fetal_growth/weight/ | 0.16708146 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.13608976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.68044534 |
| 2 | Nemaline bodies (HP:0003798) | 9.20548056 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.65353382 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.83788828 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 7.67376601 |
| 6 | Distal arthrogryposis (HP:0005684) | 7.62031500 |
| 7 | Myopathic facies (HP:0002058) | 6.91284150 |
| 8 | Round ear (HP:0100830) | 6.61376953 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 6.52069297 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.41991272 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 5.67307995 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.62390558 |
| 13 | Deformed tarsal bones (HP:0008119) | 5.41130665 |
| 14 | Difficulty running (HP:0009046) | 5.36801553 |
| 15 | Absent phalangeal crease (HP:0006109) | 5.17145398 |
| 16 | Muscle fiber splitting (HP:0003555) | 5.13544430 |
| 17 | Myoglobinuria (HP:0002913) | 5.12754871 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 4.70416203 |
| 19 | Muscle stiffness (HP:0003552) | 4.57825331 |
| 20 | Increased connective tissue (HP:0009025) | 4.51064596 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.43064692 |
| 22 | Abnormal finger flexion creases (HP:0006143) | 4.32760507 |
| 23 | Rhabdomyolysis (HP:0003201) | 4.27576592 |
| 24 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.06421710 |
| 25 | Myotonia (HP:0002486) | 3.99129398 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.88436281 |
| 27 | Malignant hyperthermia (HP:0002047) | 3.75729869 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 3.57477267 |
| 29 | Neck muscle weakness (HP:0000467) | 3.52618862 |
| 30 | Abnormality of the calcaneus (HP:0008364) | 3.40836604 |
| 31 | Frequent falls (HP:0002359) | 3.35489762 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.34702712 |
| 33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.34567528 |
| 34 | Subaortic stenosis (HP:0001682) | 3.34567528 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.30013206 |
| 36 | Shoulder girdle muscle weakness (HP:0003547) | 3.09035189 |
| 37 | Pelvic girdle muscle weakness (HP:0003749) | 3.08722538 |
| 38 | Areflexia of lower limbs (HP:0002522) | 2.98528614 |
| 39 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.98441744 |
| 40 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.98441744 |
| 41 | Slender build (HP:0001533) | 2.93761388 |
| 42 | Hyperkalemia (HP:0002153) | 2.93023982 |
| 43 | Fatigable weakness (HP:0003473) | 2.69519061 |
| 44 | Abnormality of the neuromuscular junction (HP:0003398) | 2.69519061 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.66666604 |
| 46 | Bundle branch block (HP:0011710) | 2.65943412 |
| 47 | Paralysis (HP:0003470) | 2.56069285 |
| 48 | EMG: neuropathic changes (HP:0003445) | 2.46036495 |
| 49 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45214362 |
| 50 | Sudden death (HP:0001699) | 2.42883134 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.41717169 |
| 52 | Bulbar palsy (HP:0001283) | 2.32767036 |
| 53 | Spinal rigidity (HP:0003306) | 2.31894161 |
| 54 | Dilated cardiomyopathy (HP:0001644) | 2.31202725 |
| 55 | Muscular dystrophy (HP:0003560) | 2.28966366 |
| 56 | Generalized muscle weakness (HP:0003324) | 2.26863659 |
| 57 | Ulnar deviation of finger (HP:0009465) | 2.23157656 |
| 58 | Metatarsus adductus (HP:0001840) | 2.23030981 |
| 59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.22511023 |
| 60 | Fetal akinesia sequence (HP:0001989) | 2.19991834 |
| 61 | Nonprogressive disorder (HP:0003680) | 2.17337788 |
| 62 | Hypoplastic ischia (HP:0003175) | 2.16036317 |
| 63 | Limb-girdle muscle weakness (HP:0003325) | 2.15469248 |
| 64 | Proximal amyotrophy (HP:0007126) | 2.10601523 |
| 65 | Scapular winging (HP:0003691) | 2.09272148 |
| 66 | Facial diplegia (HP:0001349) | 2.06188586 |
| 67 | Gowers sign (HP:0003391) | 2.03646351 |
| 68 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.03509924 |
| 69 | Weak cry (HP:0001612) | 2.03439019 |
| 70 | Muscle fiber inclusion bodies (HP:0100299) | 10.0205343 |
| 71 | Lipoatrophy (HP:0100578) | 1.98356204 |
| 72 | Limb-girdle muscle atrophy (HP:0003797) | 1.96899865 |
| 73 | Abnormality of the foot musculature (HP:0001436) | 1.94997305 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 1.94799395 |
| 75 | Tarsal synostosis (HP:0008368) | 1.90301073 |
| 76 | Abnormality of the ischium (HP:0003174) | 1.88397095 |
| 77 | Popliteal pterygium (HP:0009756) | 1.86154898 |
| 78 | Waddling gait (HP:0002515) | 1.85666847 |
| 79 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.84435415 |
| 80 | Foot dorsiflexor weakness (HP:0009027) | 1.82573321 |
| 81 | Achilles tendon contracture (HP:0001771) | 1.82331007 |
| 82 | Progressive muscle weakness (HP:0003323) | 1.77698523 |
| 83 | Exercise intolerance (HP:0003546) | 1.76679375 |
| 84 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.74563939 |
| 85 | Heart block (HP:0012722) | 1.72953575 |
| 86 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.71276415 |
| 87 | Synostosis involving bones of the feet (HP:0009140) | 1.71276415 |
| 88 | Hip contracture (HP:0003273) | 1.67474591 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 1.65746403 |
| 90 | Type 2 muscle fiber atrophy (HP:0003554) | 1.63440674 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 1.62508495 |
| 92 | Ventricular tachycardia (HP:0004756) | 1.62343155 |
| 93 | Ragged-red muscle fibers (HP:0003200) | 1.61839560 |
| 94 | Mesomelia (HP:0003027) | 1.60990032 |
| 95 | Stridor (HP:0010307) | 1.57670214 |
| 96 | Short palpebral fissure (HP:0012745) | 1.56028638 |
| 97 | Adducted thumb (HP:0001181) | 1.54772343 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.54426975 |
| 99 | Long clavicles (HP:0000890) | 1.53714722 |
| 100 | Congenital hip dislocation (HP:0001374) | 1.53277015 |
| 101 | Cholelithiasis (HP:0001081) | 1.53230499 |
| 102 | Increased density of long bones (HP:0006392) | 1.53229620 |
| 103 | Muscle fiber atrophy (HP:0100295) | 1.51833931 |
| 104 | Increased purine levels (HP:0004368) | 1.50789955 |
| 105 | Hyperuricemia (HP:0002149) | 1.50789955 |
| 106 | Fibular aplasia (HP:0002990) | 1.50307509 |
| 107 | Abnormality of potassium homeostasis (HP:0011042) | 1.49890653 |
| 108 | Gout (HP:0001997) | 1.49344462 |
| 109 | Limited hip movement (HP:0008800) | 1.48045937 |
| 110 | Increased intramyocellular lipid droplets (HP:0012240) | 1.44844881 |
| 111 | Lower limb amyotrophy (HP:0007210) | 1.42958567 |
| 112 | Ventricular arrhythmia (HP:0004308) | 1.41255762 |
| 113 | Wrist flexion contracture (HP:0001239) | 1.36782303 |
| 114 | Amniotic constriction ring (HP:0009775) | 1.35261871 |
| 115 | Abnormality of placental membranes (HP:0011409) | 1.35261871 |
| 116 | Increased muscle lipid content (HP:0009058) | 1.35113120 |
| 117 | Oligomenorrhea (HP:0000876) | 1.34862155 |
| 118 | Abnormal gallbladder morphology (HP:0012437) | 1.34615128 |
| 119 | Steppage gait (HP:0003376) | 1.32525194 |
| 120 | Easy fatigability (HP:0003388) | 1.24069459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.41825204 |
| 2 | TTN | 6.25790729 |
| 3 | PHKG1 | 5.79398672 |
| 4 | PHKG2 | 5.79398672 |
| 5 | NME1 | 4.20719536 |
| 6 | PIK3CG | 4.06252643 |
| 7 | MAP2K3 | 2.87433913 |
| 8 | NEK1 | 2.34078392 |
| 9 | MAP3K7 | 2.13464768 |
| 10 | TRIB3 | 1.96564793 |
| 11 | PINK1 | 1.88549454 |
| 12 | PDK4 | 1.83488533 |
| 13 | PDK3 | 1.83488533 |
| 14 | PIK3CA | 1.67490364 |
| 15 | DMPK | 1.62851464 |
| 16 | MAPK12 | 1.62225825 |
| 17 | MAP2K4 | 1.61564913 |
| 18 | BCKDK | 1.48134162 |
| 19 | MAP2K6 | 1.42005962 |
| 20 | MUSK | 1.22547642 |
| 21 | PDK2 | 1.21468456 |
| 22 | MAPKAPK3 | 1.00288274 |
| 23 | CCNB1 | 1.00069153 |
| 24 | MAP3K3 | 0.99722870 |
| 25 | MARK1 | 0.87904255 |
| 26 | PRKAA2 | 0.86038478 |
| 27 | NEK9 | 0.83220785 |
| 28 | PRKAA1 | 0.81005562 |
| 29 | TAOK2 | 0.73969565 |
| 30 | ERBB3 | 0.71967528 |
| 31 | TRPM7 | 0.70360969 |
| 32 | PKN2 | 0.67142707 |
| 33 | TAOK1 | 0.66203613 |
| 34 | MAPK11 | 0.64129741 |
| 35 | MAP3K13 | 0.63678130 |
| 36 | STK24 | 0.62762916 |
| 37 | EPHB1 | 0.62422694 |
| 38 | SIK1 | 0.60462005 |
| 39 | MAP3K11 | 0.60162072 |
| 40 | RIPK1 | 0.58844683 |
| 41 | CAMK2G | 0.57768837 |
| 42 | CAMK4 | 0.57269189 |
| 43 | AKT2 | 0.56249116 |
| 44 | EEF2K | 0.47412705 |
| 45 | ZAK | 0.47117604 |
| 46 | PTK6 | 0.42565519 |
| 47 | ILK | 0.41632494 |
| 48 | LIMK1 | 0.39967039 |
| 49 | CAMK1 | 0.38217359 |
| 50 | ERN1 | 0.36474719 |
| 51 | KSR2 | 0.35670762 |
| 52 | MAP3K6 | 0.35628211 |
| 53 | CAMK2B | 0.34510937 |
| 54 | CAMK2A | 0.34440153 |
| 55 | SGK1 | 0.33503809 |
| 56 | MAP3K1 | 0.32715442 |
| 57 | SGK2 | 0.32247473 |
| 58 | RPS6KB1 | 0.30130165 |
| 59 | MAP3K5 | 0.28935128 |
| 60 | MAPK13 | 0.28146630 |
| 61 | PRKG1 | 0.28136519 |
| 62 | MAP3K10 | 0.26964208 |
| 63 | TBK1 | 0.26494698 |
| 64 | PRKACB | 0.26253252 |
| 65 | RPS6KA3 | 0.24986200 |
| 66 | MOS | 0.24838440 |
| 67 | MAP2K1 | 0.23640272 |
| 68 | LATS1 | 0.23559634 |
| 69 | DDR2 | 0.21708949 |
| 70 | PKN1 | 0.21630121 |
| 71 | MAPK4 | 0.21381637 |
| 72 | MAPK7 | 0.20879167 |
| 73 | LATS2 | 0.20159719 |
| 74 | ROCK1 | 0.19178461 |
| 75 | ARAF | 0.19050014 |
| 76 | MARK2 | 0.18553935 |
| 77 | MARK3 | 0.18420430 |
| 78 | PRKACA | 0.18406251 |
| 79 | CAMK1G | 0.17768306 |
| 80 | MST1R | 0.17420966 |
| 81 | FER | 0.16774870 |
| 82 | PRKD1 | 0.16318180 |
| 83 | DYRK1B | 0.16057149 |
| 84 | CDK19 | 0.15997069 |
| 85 | PDPK1 | 0.15850453 |
| 86 | SGK223 | 0.15184539 |
| 87 | SGK494 | 0.15184539 |
| 88 | PRPF4B | 0.14797106 |
| 89 | TGFBR2 | 0.14566661 |
| 90 | TYK2 | 0.14467080 |
| 91 | PAK6 | 0.13724193 |
| 92 | LRRK2 | 0.13633647 |
| 93 | FGFR1 | 0.13606195 |
| 94 | TIE1 | 0.13125048 |
| 95 | RPS6KL1 | 0.11759291 |
| 96 | RPS6KC1 | 0.11759291 |
| 97 | ICK | 0.11387926 |
| 98 | PDK1 | 0.10732456 |
| 99 | BMX | 0.10569872 |
| 100 | DAPK2 | 0.09574428 |
| 101 | RAF1 | 0.08312366 |
| 102 | RPS6KA1 | 0.08144197 |
| 103 | RPS6KA6 | 0.07943122 |
| 104 | INSRR | 0.05862949 |
| 105 | BRAF | 0.05811637 |
| 106 | ZAP70 | 0.05533529 |
| 107 | MTOR | 0.05401496 |
| 108 | NLK | 0.04987272 |
| 109 | GSK3A | 0.04591245 |
| 110 | PRKACG | 0.04144762 |
| 111 | MAPK10 | 0.04061793 |
| 112 | ROCK2 | 0.03866986 |
| 113 | JAK2 | 0.03854563 |
| 114 | RPS6KB2 | 0.03615889 |
| 115 | GSK3B | 0.02738005 |
| 116 | MAPK8 | 0.02694156 |
| 117 | RET | 0.02370584 |
| 118 | STK11 | 0.01931814 |
| 119 | CSNK1D | 0.01738403 |
| 120 | SGK3 | 0.01570388 |
| 121 | FGFR3 | 0.01343702 |
| 122 | CAMK2D | 0.00826288 |
| 123 | KSR1 | 0.00815378 |
| 124 | PTK2B | 0.00779428 |
| 125 | RPS6KA2 | -0.0196481 |
| 126 | PDGFRA | -0.0091165 |
| 127 | MAPK9 | -0.0069329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.23970502 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.03403565 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.88340817 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.39359222 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.37225614 |
| 6 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.20479454 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.18514965 |
| 8 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.46956635 |
| 9 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.38841522 |
| 10 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.35722077 |
| 11 | Circadian rhythm_Homo sapiens_hsa04710 | 2.30404789 |
| 12 | Insulin resistance_Homo sapiens_hsa04931 | 2.23064413 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.22948603 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19839068 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.13660362 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.85608108 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.83731314 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.82649036 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.74595641 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72385602 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58943409 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.55668980 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54362526 |
| 24 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49840816 |
| 25 | Tight junction_Homo sapiens_hsa04530 | 1.49217700 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.38548360 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35109309 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33947070 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29894973 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29686167 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29313170 |
| 32 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.27871784 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24614721 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21352991 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20504137 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.19266934 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15285167 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09435107 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08963890 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07810181 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.02629080 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00375394 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97990412 |
| 44 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97257220 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91871746 |
| 46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89749508 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83622931 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83363357 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82911072 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78667070 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78450617 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.77710724 |
| 53 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76638400 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73509445 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67368557 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62926858 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.62716157 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56155141 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.54545855 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53822101 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53667903 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50898858 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.50890243 |
| 64 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49541826 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 0.47471758 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46870533 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43284618 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.43128876 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42771637 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36728749 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35931755 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.35757026 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35575812 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35203261 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33228975 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32483309 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.31851536 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31844882 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31302862 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29890921 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29712971 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28965173 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27359102 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26993196 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25378622 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.25367885 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.24986717 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.22725555 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22555812 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21738196 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21571812 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.20589456 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20378866 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18014680 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17632350 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.15400459 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.15231954 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14833284 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.14325814 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13755624 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.13442823 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12838110 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.12528908 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.12487741 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.10424067 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.10319015 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10267968 |
| 108 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.10117582 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.08090672 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.07383823 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.06224979 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.05485734 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.04525854 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.04315642 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.04209840 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.04190576 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.04081199 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03680898 |

